MORRISVILLE, N.C. , Jan. 22, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2019 financial results on Thursday, February 20, 2020 , prior to its earnings call at 8:00 a.m.

Omnipresence Platform Provides Biopharmaceutical Companies Advanced Analytics, AI and Cloud Innovations Powered by Microsoft MORRISVILLE, N.C. , Jan. 09, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced a strategic

MORRISVILLE, N.C. , Jan. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO ( Contract Commercial Organization ), today announced that Chief Executive Officer